From Name:
From Email:
To Name:
To Email:

Optional Message:

How will rescheduling of hydrocodone combo products affect you, your patients?

from AAFP

From Oct. 14: The DEA recently published its final rule in the Federal Register that moved hydrocodone combination products from Schedule III to the more restrictive Schedule II, as was recommended by the HHS assistant secretary. The rule takes effect Oct. 6, so family physicians need to prepare for what this change will mean for their patients, as well as for their own day-to-day operations. more

Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063